CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Calcipotriene And Bethamethasone Dipropionate, and when can generic versions of Calcipotriene And Bethamethasone Dipropionate launch?
Calcipotriene And Bethamethasone Dipropionate is a drug marketed by Padagis Israel and is included in one NDA.
The generic ingredient in CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE is betamethasone dipropionate; calcipotriene. There are sixty-six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate; calcipotriene profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE?
- What are the global sales for CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE?
- What is Average Wholesale Price for CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE?
Summary for CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE at DailyMed |
Pharmacology for CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE
| Drug Class | Corticosteroid Vitamin D Analog |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Padagis Israel | CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE | betamethasone dipropionate; calcipotriene | SUSPENSION;TOPICAL | 212367-001 | Sep 11, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
